1-4 of 4
Authors: M Tokmakova
Sort by
Journal Article
Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial Free
K Jering and others
European Heart Journal, Volume 45, Issue Supplement_1, October 2024, ehae666.1589, https://doi.org/10.1093/eurheartj/ehae666.1589
Published: 28 October 2024
Journal Article
A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure Free
J E Udelson and others
European Heart Journal, Volume 45, Issue Supplement_1, October 2024, ehae666.1081, https://doi.org/10.1093/eurheartj/ehae666.1081
Published: 28 October 2024
Journal Article
Atrial fibrillation in patients with high-risk acute myocardial infarction – the PARADISE-MI trial Free
M Cikes and others
European Heart Journal, Volume 43, Issue Supplement_2, October 2022, ehac544.1178, https://doi.org/10.1093/eurheartj/ehac544.1178
Published: 03 October 2022
Journal Article
A non-invasively determined surrogate of cardiac power (‘circulatory power’) at peak exercise is a powerful prognostic factor in chronic heart failure
Get access
A. Cohen-Solal and others
European Heart Journal, Volume 23, Issue 10, 1 May 2002, Pages 806–814, https://doi.org/10.1053/euhj.2001.2966
Published: 01 May 2002
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals